Fennec Pharmaceuticals Inc..
FENC.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Fennec Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for pediatric oncology. Its primary product candidate is PEDMARK™, a formulation of sodium thiosulfate (STS) designed to prevent ototoxicity (hearing loss) induced by platinum-based chemotherapy in children wi...Show More
Better Health for All
0
No specific, concrete data points relevant to any of the KPIs for 'Better Health for All' were found in the provided articles for Fennec Pharmaceuticals Inc. The articles either pertained to a different company, were inaccessible, or explicitly stated they contained no relevant information for the requested metrics or the company's overall performance.
Fair Money & Economic Opportunity
0
Fennec Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for pediatric oncology. Its core business involves the development and commercialization of pharmaceutical products, not financial services. The provided articles discuss product sales, financial performance, and patient support programs related to its medication, PEDMARK™.
1
There is no evidence that the company engages in activities such as lending, insuring, moving, or storing money, nor does it offer consumer financial products or services.
2
Therefore, none of the Key Performance Indicators (KPIs) related to 'Fair Money & Economic Opportunity' are applicable to Fennec Pharmaceuticals Inc., and no relevant evidence was found in the provided articles to score any of these KPIs.
Fair Pay & Worker Respect
0
The provided articles do not contain specific, concrete data points for any of the KPIs related to Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, turnover rate, labor violation incidents, insecure contract share, or health insurance coverage is explicitly stated as missing or not provided.
1
While class action lawsuits are mentioned,
2
their nature is not specified as labor-law or human-rights violations, and other statements explicitly note no data on labor violations or compliance issues.
3
Fair Trade & Ethical Sourcing
0
No evidence available to assess Fennec Pharmaceuticals Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No evidence available to assess Fennec Pharmaceuticals Inc. on Honest & Fair Business.
Kind to Animals
0
The provided articles discuss the FDA's policies and initiatives regarding the reduction of animal testing in drug development, including the FDA Modernization Act 2.0 and the agency's plans to encourage alternative testing methods.
1
However, neither article provides any specific information, data points, or policies directly attributable to Fennec Pharmaceuticals Inc. (FENC.US) concerning its own animal testing practices, cruelty-free certifications, humane operations, ethical sourcing, or any other animal welfare-related activities. Therefore, there is no evidence to assess FENC.US against any of the 'Kind to Animals' KPIs.
No War, No Weapons
0
No evidence available to assess Fennec Pharmaceuticals Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles explicitly state a lack of specific, concrete data points for all Planet-Friendly Business KPIs. Information regarding environmental sustainability, including emissions, renewable energy use, water usage, waste diversion, climate targets, and environmental compliance, is consistently noted as 'Not applicable' or 'No data found'.
1
Therefore, no KPIs can be scored based on the evidence provided.
Respect for Cultures & Communities
0
No specific information or concrete data points relevant to Fennec Pharmaceuticals Inc.'s 'Respect for Cultures & Communities' value, or any of the associated KPIs, were found in the provided articles. The articles either explicitly stated a lack of relevant data, discussed unrelated market information, or were inaccessible due to technical errors.
Safe & Smart Tech
0
Fennec Pharmaceuticals Inc. has no documented data breaches.
1
The company demonstrates good compliance with applicable regulations, having received FDA approval for PEDMARK® in September 2022, European Commission Marketing Authorization for PEDMARQSI® in June 2023, and UK approval in October 2023.
2
It also holds Orphan Drug Exclusivity for PEDMARK® and Pediatric Use Marketing Authorization (PUMA) in the EU.
3
Zero Waste & Sustainable Products
0
No evidence available to assess Fennec Pharmaceuticals Inc. on Zero Waste & Sustainable Products.